\-\ Texto\\:\\ \ \(0\)\
\-\ no\\ recent\\ labs\\.\ \(0\)\
\-\ due\\ to\\ the\\ extensive\\ vascular\\ involvement\\ the\\ patient\\'s\\ tumor1\\ was\\ considered\\ non\\-operable\\ and\\ the\\ patient\\ went\\ on\\ to\\ receive\\ chemotherapy\\.\ \(0\)\
\-\ pancreatic\\ head\\ mass\\ w\\/\\ pancreatic\\ ductal\\ dilatation\ \(0\)\
\-\ pancreatic\\ adenocarcinoma\ \(3\)\
\-\ the\\ aggressive\\ appearance\\ of\\ this\\ lesion\\ is\\ highly\\ suggestive\\ of\\ adenocarcionoma\\.\\ based\\ upon\\ imaging\\ characteristics\\ cystic\\ neoplasms\\ such\\ as\\ mucinous\\ cystadenoma\\ and\\ mucinous\\ cystadenocarcinoma\\ would\\ also\\ be\\ included\\ in\\ the\\ differential\\ diagnosis\\.\\ these\\,\\ however\\,\\ tend\\ to\\ occur\\ in\\ younger\\ patients\\.\\ \\ islet\\ cell\\ tumors\\ tend\\ to\\ be\\ hypervascular\\.\\ \\ an\\ abscess\\ secondary\\ to\\ pancreatitis\\ would\\ be\\ expected\\ to\\ have\\ a\\ more\\ cystic\\ and\\ less\\ infiltrative\\ appearance\\.\ \(0\)\
\-\ 78\\ year\\ old\\ female\\ with\\ epigastric\\ pain\\ radiating\\ to\\ the\\ back\\ and\\ twenty\\ pound\\ weight\\ loss\\.\ \(1\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ pancreatic\\:\\ 0\\.10197047404236251\ \(0\)\
\-\ mucinous\\:\\ 0\\.08335998324963516\ \(0\)\
\-\ tend\\:\\ 0\\.07878417090104678\ \(0\)\
\-\ tumor1\\:\\ 0\\.0716708814956626\ \(0\)\
\-\ non\\-operable\\:\\ 0\\.0716708814956626\ \(0\)\
\-\ adenocarcionoma\\:\\ 0\\.0716708814956626\ \(0\)\
\-\ pound\\:\\ 0\\.05295067748758092\ \(0\)\
\-\ islet\\:\\ 0\\.05021513084838407\ \(0\)\
\-\ would\\:\\ 0\\.04944661590930228\ \(0\)\
\-\ twenty\\:\\ 0\\.048171924114392965\ \(0\)\
\-\ cystadenocarcinoma\\:\\ 0\\.04691866655482175\ \(0\)\
\-\ 78\\:\\ 0\\.042097010278374904\ \(0\)\
\-\ hypervascular\\:\\ 0\\.041092018766446636\ \(0\)\
\-\ receive\\:\\ 0\\.04090511211421331\ \(0\)\
\-\ epigastric\\:\\ 0\\.04072240596907463\ \(0\)\
\-\ younger\\:\\ 0\\.040543715670548\ \(0\)\
\-\ cystadenoma\\:\\ 0\\.040368868473629596\ \(0\)\
\-\ cystic\\:\\ 0\\.04007532857319933\ \(0\)\
\-\ infiltrative\\:\\ 0\\.03986581641088091\ \(0\)\
\-\ appearance\\:\\ 0\\.039738318320888484\ \(0\)\
\-\ pancreatitis\\:\\ 0\\.0381169434058651\ \(0\)\
\-\ radiating\\:\\ 0\\.03724725137698568\ \(0\)\
\-\ went\\:\\ 0\\.0370149475359771\ \(0\)\
\-\ w\\/\\:\\ 0\\.03604464869343591\ \(0\)\
\-\ neoplasms\\:\\ 0\\.03536268540903996\ \(0\)\
\-\ characteristics\\:\\ 0\\.03456235961381027\ \(0\)\
\-\ aggressive\\:\\ 0\\.033990158014120836\ \(0\)\
\-\ expected\\:\\ 0\\.03383380547812175\ \(0\)\
\-\ highly\\:\\ 0\\.03345559396889498\ \(0\)\
\-\ ductal\\:\\ 0\\.0327481843998736\ \(0\)\
\-\ be\\:\\ 0\\.032140407886437294\ \(0\)\
\-\ included\\:\\ 0\\.032035130900531276\ \(0\)\
\-\ adenocarcinoma\\:\\ 0\\.030012637760676746\ \(0\)\
\-\ dilatation\\:\\ 0\\.029774201865599346\ \(0\)\
\-\ suggestive\\:\\ 0\\.02968075162636573\ \(0\)\
\-\ upon\\:\\ 0\\.028394377600228376\ \(0\)\
\-\ considered\\:\\ 0\\.028045060235322335\ \(0\)\
\-\ extensive\\:\\ 0\\.027783379857306875\ \(0\)\
\-\ based\\:\\ 0\\.026493417579406184\ \(0\)\
\-\ tumors\\:\\ 0\\.02609525494041058\ \(0\)\
\-\ occur\\:\\ 0\\.026065419746191372\ \(0\)\
\-\ involvement\\:\\ 0\\.025462915907543227\ \(0\)\
\-\ chemotherapy\\:\\ 0\\.02490199825317777\ \(0\)\
\-\ weight\\:\\ 0\\.02490199825317777\ \(0\)\
\-\ to\\:\\ 0\\.02430468909838133\ \(0\)\
\-\ labs\\:\\ 0\\.024162390300285677\ \(0\)\
\-\ less\\:\\ 0\\.02352796751481856\ \(0\)\
\-\ recent\\:\\ 0\\.023355439421461767\ \(0\)\
\-\ back\\:\\ 0\\.02291923849875998\ \(0\)\
\-\ vascular\\:\\ 0\\.022778888357103226\ \(0\)\
\-\ differential\\:\\ 0\\.022056583978479104\ \(0\)\
\-\ abscess\\:\\ 0\\.021966148326294857\ \(0\)\
\-\ such\\:\\ 0\\.021718152762933762\ \(0\)\
\-\ loss\\:\\ 0\\.020166375385922274\ \(0\)\
\-\ head\\:\\ 0\\.019704075695722734\ \(0\)\
\-\ secondary\\:\\ 0\\.019423007857795185\ \(0\)\
\-\ however\\:\\ 0\\.01934445573656155\ \(0\)\
\-\ cell\\:\\ 0\\.018766184647003956\ \(0\)\
\-\ due\\:\\ 0\\.018538838641893006\ \(0\)\
\-\ these\\:\\ 0\\.018080038145998702\ \(0\)\
\-\ patients\\:\\ 0\\.017980281295658748\ \(0\)\
\-\ more\\:\\ 0\\.017375417148879403\ \(0\)\
\-\ imaging\\:\\ 0\\.01627702296305368\ \(0\)\
\-\ diagnosis\\:\\ 0\\.015953002689271707\ \(0\)\
\-\ \\'s\\:\\ 0\\.015317452181845896\ \(0\)\
\-\ have\\:\\ 0\\.01504421201922839\ \(0\)\
\-\ female\\:\\ 0\\.014282603832909219\ \(0\)\
\-\ lesion\\:\\ 0\\.014150855495938657\ \(0\)\
\-\ patient\\:\\ 0\\.01392832407994127\ \(0\)\
\-\ also\\:\\ 0\\.013696094257480907\ \(0\)\
\-\ as\\:\\ 0\\.010508760210521365\ \(0\)\
\-\ mass\\:\\ 0\\.009662284609329793\ \(0\)\
\-\ an\\:\\ 0\\.009607031416949024\ \(0\)\
\-\ pain\\:\\ 0\\.008484619248217357\ \(0\)\
\-\ was\\:\\ 0\\.008034776603363308\ \(0\)\
\-\ this\\:\\ 0\\.007814123685480756\ \(0\)\
\-\ year\\:\\ 0\\.0077732135713245104\ \(0\)\
\-\ old\\:\\ 0\\.007113289405384185\ \(0\)\
\-\ no\\:\\ 0\\.006995480900030911\ \(0\)\
\-\ in\\:\\ 0\\.006851987481955366\ \(0\)\
\-\ the\\:\\ 0\\.006743867546518332\ \(0\)\
\-\ on\\:\\ 0\\.005885292783458765\ \(0\)\
\-\ and\\:\\ 0\\.005853951405925804\ \(0\)\
\-\ is\\:\\ 0\\.004571469742965249\ \(0\)\
\-\ \\,\\:\\ 0\\.004401789683207926\ \(0\)\
\-\ a\\:\\ 0\\.0032243886326715552\ \(0\)\
\-\ \\.\\:\\ 0\\.002308912916900571\ \(0\)\
\-\ of\\:\\ 0\\.001894370744682739\ \(0\)\
\-\ with\\:\\ 0\\.0009512534641454451\ \(0\)\
